XTL Biopharmaceuticals Ltd SEC filings XTLB
XTL Biopharmaceuticals Ltd has 546 filings in SEC EDGAR's recent list, going back to Nov 17, 2004. Its latest annual report, Form 20-F, was filed on Jun 30, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Oct 14, 2026.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B3 | Prospectus | Jun 9, 2021 | — |
| POS AM | Post-effective amendment no. 1 to form f-1 | Jun 2, 2021 | — |
| 424B3 | Prospectus | Mar 7, 2018 | — |
| F-1/A | Filing | Feb 28, 2018 | — |
| F-1/A | Filing | Feb 1, 2018 | — |
| 424B5 | Prospectus supplement | Feb 22, 2017 | — |
| F-1/A | Filing | Nov 8, 2016 | — |
| F-1 | Registration statement (foreign issuer) | Dec 31, 2015 | — |
| 424B5 | Prospectus supplement | Apr 1, 2015 | — |
| FWP | Free writing prospectus | Sep 26, 2014 | — |
| 424B5 | Prospectus supplement | Sep 26, 2014 | — |
| F-3/A | Form f-3/a | Apr 4, 2014 | — |
| F-3/A | Form f-3/a | Apr 2, 2014 | — |
| F-3 | Shelf registration (foreign issuer) | Mar 5, 2014 | — |
| 424B3 | Prospectus | Oct 4, 2012 | — |
| 424B3 | Prospectus | Jan 19, 2010 | — |
| S-8 | Employee stock plan registration | Oct 28, 2008 | — |
| S-8 POS | Filing | Oct 28, 2008 | — |
| S-8 POS | Filing | Oct 28, 2008 | — |
| F-3/A | Filing | Sep 5, 2008 | — |
| F-3 | Shelf registration (foreign issuer) | Aug 15, 2008 | — |
| S-8 | Employee stock plan registration | Jan 18, 2008 | — |
| S-8 POS | Filing | Jan 18, 2008 | — |
| S-8 | Employee stock plan registration | Dec 14, 2007 | — |
| F-6EF | Form f-6 | Nov 28, 2007 | — |
| F-3/A | Filing | Nov 20, 2007 | — |
| F-3/A | Filing | Nov 13, 2007 | — |
| F-3 | Shelf registration (foreign issuer) | Oct 30, 2007 | — |
| 424B3 | Prospectus | Mar 29, 2007 | — |
| F-3 | Shelf registration (foreign issuer) | Mar 23, 2007 | — |
| 424B3 | Prospectus | May 23, 2006 | — |
| F-1 | Registration statement (foreign issuer) | Apr 21, 2006 | — |
| F-6 | Form f-6 | Jul 28, 2005 | — |
Showing 33 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- XTLB (Nasdaq)
- Incorporated in
- Israel
- Headquarters
- New York, NY
- SEC filer status
- Non-accelerated filer
- SEC CIK
- 1023549
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.